Insulet (PODD) Asset Writedowns and Impairment (2010 - 2026)
Insulet's (PODD) quarterly Asset Writedowns and Impairment came in at $300000.0 in Q1 2026, down 93.62% YoY from $4.7 million in Q1 2025, and up 200.0% on a QoQ basis from $100000.0 in Q3 2025.
Insulet (PODD) Asset Writedowns and Impairment (2010 - 2026) Analysis & Trends
Insulet (PODD) has 17 years of Asset Writedowns and Impairment data on file, last reported at $300000.0 in Q1 2026.
- Quarterly Asset Writedowns and Impairment fell 93.62% year-over-year to $300000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.5 million (up 71.88% YoY) and the FY2024 annual result came in at -$200000.0, down 108.7% from the prior year.
- Asset Writedowns and Impairment advanced to $300000.0 in Q1 2026, from $100000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $4.7 million in Q1 2025 to a low of -$900000.0 in Q4 2024.
- A 5-year average of $780000.0 and a median of $800000.0 in 2022 frame the typical range for Asset Writedowns and Impairment.
- Annual changes were most pronounced in 2022 — Asset Writedowns and Impairment soared 450.0% — and 2024, when it plunged 550.0%.
- Tracing PODD's Asset Writedowns and Impairment over 5 years: stood at $1.1 million in 2022, then slumped by 81.82% to $200000.0 in 2023, then sank by 550.0% to -$900000.0 in 2024, then jumped by 111.11% to $100000.0 in 2025, then surged by 200.0% to $300000.0 in 2026.
- The last three Asset Writedowns and Impairment figures came in at $300000.0 (Q1 2026), $100000.0 (Q3 2025), and $400000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Insulet | 10.27 Bn | 9.74 Bn | 562.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 400,000.00 |
| Jun 30, 2026 | 400,000.00 |
| Mar 31, 2026 | 300,000.00 |
| Mar 31, 2026 | 300,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Mar 31, 2025 | 4.70 Mn |
| Mar 31, 2025 | 4.70 Mn |
| Dec 31, 2024 | -900,000.00 |
| Dec 31, 2024 | -900,000.00 |
| Jun 30, 2024 | -600,000.00 |
| Jun 30, 2024 | -600,000.00 |
| Mar 31, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.20 Mn |
| Dec 31, 2023 | 200,000.00 |
| Dec 31, 2023 | 200,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Sep 30, 2023 | 100,000.00 |